| Clinical EAE after adoptive transfer | Clinical EAE after antigenic challenge | ||||||
| Strain | Antigen | incidence | Av. disease grade (range) | Av. day of onset (range) | Incidence | Av. disease grade (range) | Av. day of onset (range) |
| SJL | MBP | 21/21 | 4.0 (3-5) | 8.0 (6-10) | N.D. | N.D. | N.D. |
| C57BL/6 | MBP | 0/10 | - - | - - | 7/7 | 3.85 (3-5) | 9.28 (9-10) |
| Balb/c | MBP | 0/7 | - - | - - | 5/5 | 3.2 (3-4) | 7.0 (7) |
| C3H/HeJ | MBP | 0/7 | - - | - - | 4/4 | 3.2 (3-4) | 8.0 (8) |
| C57BL/6 | MBP60-80 | 0/4 | - - | - - | 4/4 | 2.75 (2-4) | 10.2 (9-11) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.